Physician- and patient-reported barriers to hepatocellular carcinoma surveillance: A nationwide survey.
暂无分享,去创建一个
P. Tangkijvanich | R. Chaiteerakij | R. Rerknimitr | S. Treeprasertsuk | Chonlada Phathong | Tongluk Teerasarntipan | Yingluk Sritunyarat | Parinda Prathyajuta | Palada Pitakkitnukun | Darlene Ariyaskul | Kittipat Kulkraisri
[1] J. Kramer,et al. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort , 2022, JAMA network open.
[2] T. Yokoo,et al. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study , 2022, Alimentary pharmacology & therapeutics.
[3] Haesuk Park,et al. Surveillance of patients with cirrhosis remains suboptimal in the United States. , 2021, Journal of hepatology.
[4] G. Abou-Alfa,et al. Hepatocellular Carcinoma in Sub-Saharan Africa , 2021, JCO global oncology.
[5] A. Movsisyan,et al. When complexity matters: a step-by-step guide to incorporating a complexity perspective in guideline development for public health and health system interventions , 2020, BMC Medical Research Methodology.
[6] P. Perumalswami,et al. Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the U.S. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] Jasmin A. Tiro,et al. Patient-Reported Barriers are Associated with Receipt of Hepatocellular Carcinoma Surveillance in a Multi-Center Cohort of Patients with Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] V. Chongsuvivatwong,et al. Adherence to Hepatocellular Carcinoma Surveillance and Perceived Barriers Among High-Risk Chronic Liver Disease Patients in Yunnan, China , 2020, Cancer management and research.
[9] J. Marrero,et al. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐Analysis , 2020, Hepatology.
[10] S. Essig,et al. The use of ultrasound in primary care: longitudinal billing and cross-sectional survey study in Switzerland , 2020, BMC Family Practice.
[11] S. Walker,et al. Methods to promote equity in health resource allocation in low- and middle-income countries: an overview , 2020, Globalization and Health.
[12] R. Wong,et al. Disparities in Hepatocellular Carcinoma Surveillance: Dissecting the Roles of Patient, Provider, and Health System Factors. , 2020, Journal of clinical gastroenterology.
[13] M. Kumar,et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission , 2019, The Lancet Gastroenterology & Hepatology.
[14] G. Francica,et al. Status of, and strategies for improving, adherence to HCC screening and surveillance , 2019, Journal of hepatocellular carcinoma.
[15] A. Singal,et al. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] Thinakorn Noree,et al. Equity of health workforce distribution in Thailand: an implication of concentration index , 2019, Risk management and healthcare policy.
[17] D. Ramai,et al. Physician Awareness of Hepatocellular Carcinoma Surveillance in Patients With Chronic Liver Disease , 2018, American Journal of Gastroenterology.
[18] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.
[19] S. Mohanty,et al. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings , 2018, Journal of General Internal Medicine.
[20] M. Abecassis,et al. AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.
[21] R. Chaiteerakij,et al. Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis. , 2017, Annals of hepatology.
[22] S. Mohanty,et al. Integrative review: patient and provider factors related to hepatocellular carcinoma surveillance in patients with liver cirrhosis , 2017 .
[23] Jasmin A. Tiro,et al. Patient‐reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis , 2016, Hepatology.
[24] P. Wilairatana,et al. The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study. , 2015, Annals of hepatology.
[25] Sachita Shah,et al. Perceived barriers in the use of ultrasound in developing countries , 2015, Critical Ultrasound Journal.
[26] Teresa P. Edwards,et al. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] H. El‐Serag,et al. Surveillance for hepatocellular carcinoma: can we focus on the mission? , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] Jasmin A. Tiro,et al. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] T. Tanwandee,et al. Economic evaluation and budget impact analysis of the surveillance program for hepatocellular carcinoma in Thai chronic hepatitis B patients. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[30] Shigui Yang,et al. Role of general practitioners in prevention and treatment of hepatitis B in China. , 2014, Hepatobiliary & pancreatic diseases international : HBPD INT.
[31] J. Kettenbach,et al. Factors affecting screening for hepatocellular carcinoma. , 2014, Annals of hepatology.
[32] William M. Lee,et al. Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review , 2012, Journal of General Internal Medicine.
[33] Sachita Shah,et al. Review article: Use of ultrasound in the developing world , 2011, International journal of emergency medicine.
[34] Tung T. Nguyen,et al. Hepatitis B and Hepatocellular Carcinoma Screening Among Asian Americans: Survey of Safety Net Healthcare Providers , 2010, Digestive Diseases and Sciences.
[35] Xianglin L. Du,et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States , 2010, Hepatology.
[36] J. Marrero,et al. Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis , 2009, Alimentary pharmacology & therapeutics.
[37] Shanlian Hu,et al. Reform of how health care is paid for in China: challenges and opportunities , 2008, The Lancet.
[38] J. Ferrante,et al. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. , 2008, Family medicine.
[39] E. Kluge,et al. Resource allocation in healthcare: implications of models of medicine as a profession. , 2007, MedGenMed : Medscape general medicine.
[40] M. Cabana,et al. Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement , 1999 .